Ignite Creation Date:
2024-05-05 @ 9:43 PM
Last Modification Date:
2024-10-26 @ 10:08 AM
Study NCT ID:
NCT00942058
Status:
TERMINATED
Last Update Posted:
2014-01-29
First Post:
2009-06-17
Brief Title:
Serum CA9 Level as Biological Marker of the Treatment Response in Metastatic Renal Cell Cancer
Sponsor:
Organization:
Centre Hospitalier Universitaire de Saint Etienne
Study Design
Study Type:
OBSERVATIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
SAMPLES_WITHOUT_DNA
Bio Spec Description:
Blood urine
Enrollment Count:
16
Enrollment Type:
ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
| Name |
|---|
| Cohort |
Time Perspective List:
Clinical Trial Statuses
| Name |
|---|
| 8848 |
Who Masked List: